A Genetic Predisposition to Science

English
Prof. Lia Addadi: Memories from Padua

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Science is in Prof. Lia Addadi's genes. Her maternal great-grandfather was an avid collector of all types of shells, and his collection, which is considered one of the most comprehensive in the world, is now on display at the Hebrew University in Jerusalem.

Addadi, through her research on the complex relationship between proteins and crystals, studies how mollusks form their shells. But her research has provided a bridge to her great-grandfather in more ways than one.

"My great-grandfather was a civil engineer who developed an interest in a number of different areas, including shells," says Addadi, Head of the Weizmann Institute's Structural Biology Department. "My mother remembers looking with her grandfather at shells through a microscope."

 

Though he had decided to donate the collection to the University of Padua, Addadi's great-grandfather changed his mind after World War II. But he forgot to tell Addadi's great-grandmother where it should go instead. Shortly after he died in 1951, she decided to send it, as Addadi would later find out, to the Hebrew University of Jerusalem.

Addadi was born in 1950 in Padua, Italy. "Even as a child, I was interested in how things are on the inside. My interest began with the human body, but I found that anatomy was simply not enough -- I wanted to know things in greater detail. This led to my interest in chemistry and eventually brought me to the area shared by biology and structural chemistry."

After receiving her master's degree in chemistry from the University of Padua in 1973, Addadi decided to move to Israel. "As long as I can remember, I'd always wanted come to Israel," says Addadi, who recalls declaring once, at the age of 12, that she would become a scientist at the Weizmann Institute.

Since Addadi's husband was working in the center of Israel, she approached nearby universities. "At other places, I felt a bit like a beggar; they kept asking me 'Why are you here? We don't need any more graduate students.' But when I came to the Institute, I immediately felt that they really wanted me here ? that was quite a shock!"

She earned her Ph.D. under the tutelage of Prof. Meir Lahav of the Materials and Interfaces Department. "There was one particular question he was researching that really appealed to me: How is it that all the amino acids in proteins have the same symmetry? That's when I got 'hooked'." Addadi says. "The fine line between biology and chemistry also has an aesthetic appeal. For example, crystals or the skeletons that living creatures build are amazingly beautiful, especially when you look at their structure greatly magnified under an electron microscope."

Although Addadi knew about her great-grandfather's shell collection, she had no clue as to its whereabouts until she returned to the Weizmann Institute from a postdoctoral fellowship at Harvard University. She began collaborating with Steve Weiner, who had just joined the Institute and was working on biomineralization and shells. Addadi commented on the coincidence of her working on shells, considering that her great-grandfather used to collect them. "Steve then told me he knew about a wonderful collection that had been donated by a family in Venice, and that he used to go to see it to study the taxonomy of specific shells. It took but a few phone calls to verify that it was my great-grandfather's collection."

Addadi was quite pleased to find her great-grandfather's collection by way of her own research. "This really got me involved in the collection, and what amazes me is the coincidence that brought me back full circle to my family."

 

Prof. Lia Addadi
English

Outwitting the Enemy

English

 

Dr. Naomi Balaban. Carrying out her own ideas
 
 

Scientists have been trying to outsmart bacteria for a long time ­ in vain. Bacteria have been the ones to come up with ingenious ways to sidestep antibiotic attack by developing immunity to it, leading to doomsday theories on just when antibiotics won't be effective anymore.


This is precisely why a discovery by microbiologist Dr. Naomi Balaban, Feinberg Graduate School graduate, and now a microbiologist at University of California at Davis, has caused tremendous excitement worldwide. Balaban has found a way to circumvent the need for antibiotics when dealing with the potent Staphylococcus bacteria, which is responsible for 70,000 deaths yearly in America alone. Having created a whole new outlook on tackling bacteria, her method may prove useful in fighting other kinds of bacteria as well.

The problem in finding alternatives to antibiotics, she says, was the age-old strategic loophole ­ underestimating one's enemy. "Scientists always thought bacteria were passive ­ reacting to cramped conditions, yet not initiating any actions on their own. But I wondered how that could be, given the fact that they are such great survivors."

And so she set out to see whether bacteria were indeed all that, well, dim-witted. Her findings proved her suspicions were wellfounded. Balaban discovered that bacteria send out "scouts," called RAP, to check out the territory. The scouts are the eyes, ears and feelers of the bacteria: Without them, bacteria have no indication of their surroundings or whether their food supply is running low. Picking up signals from neighboring bacteria, they relay a message back to the bacteria warning that conditions are beginning to look uncomfortable.

Once a message indicating cramped conditions is sent to the bacterium, it gets out of this tight spot by chewing away at surrounding tissue (that means us), thus enlarging its space and food supply.

Balaban also found a way to neutralize the scouts. Since the scouts are the only "feelers" the bacterium has, neutralizing them means leaving the bacterium in a state of false bliss, without knowledge of its increasingly cramped surroundings. The bacterium leaves surrounding tissue alone, and infections are prevented.

Even during its final, unnourished moments, the bacterium doesn't realize that anything is amiss. And it doesn't have a chance to mutate into a stronger breed, i.e., doesn't develop immunity, as it would with antibiotics.

Balaban began studying at the Weizmann Institute in 1985, earning her Ph.D. in 1991 under the supervision of Dr. Rachel Goldman. She did her postdoctoral studies at New York University under the supervision of Prof. Richard Novick.
 
"The Weizmann Institute gave me the opportunity to be unconventional and to carry out my own ideas. That definitely set the stage for what I'm doing today. At the Weizmann Institute, which is small yet encompasses so many disciplines, ideas are frequently born just by bumping into someone. The Feinberg Graduate School is simply the best of the best."
 
Dr. Naomi Balaban
English

The Science of Chutzpah

English
Jacob Guedalia and family. Physics and business
 
 

"Physics comes in handy anytime, anywhere, because physics teaches you chutzpah." That was one of the opening sentences Jacob Guedalia heard at the Weizmann Institute while on his first interview. "In physics, you step up to the universe and say, 'I know nothing about you, but I'm going to reveal your mysteries and do things that have never been done before,' " states Guedalia. "Being an entrepreneur in the business world is the same."


Bridging the distance between physics and the business world comes naturally to Guedalia, who believes that hi-tech and tradition are complementary, that failure provides the stamina for success, and that the Weizmann Institute provided him with his business skills.

"In the Weizmann Institute's Feinberg Graduate School, I got a chance to see how really excellent people work," he says. He was only one step away from not being accepted at all. "I went completely blank during my interview. The interview lasted three hours instead of the usual half-hour. The professors told me to say something, anything about physics, so they could figure out if I knew the subject at all. It takes chutzpah to study at Weizmann." Finally, Guedalia was informed he should do courses as an external student, and on the basis of his grades, he was later accepted as a graduate student.

Guedalia's M.Sc. in physical optics would later provide a basis for his companies' technology. His objective: to shorten the time it takes to transmit images across networks. In other words, no more twiddling your thumbs as you wait for your computer to download visuals from the Internet. This would enable on-line commerce, and video phones could work over plain old telephone lines. He's accomplishing this by translating the concept on which holograms are based into computer-readable language. (See below.)

The technology of one Guedalia venture was licensed to Microsoft; the second is the Jerusalem-based OLiVR. OLiVR technology gave birth to a union between Guedalia and John Sculley of Live Picture, Inc. [Sculley is former CEO of Pepsico and Apple Computer.]

"I wake up in the morning with an idea, and then set out to see if it works ­ much like a physicist in academia. It's all about creating new worlds," says Guedalia.

And keeping in touch with traditional roots. Guedalia defines himself as orthodox, keeps kosher, and observes shabbat. "No contradiction," he says. "In Yeshiva University, where I did my undergraduate studies, we'd study Gemara half the day and physics the other half. The idea was that both make you complete."

"I definitely think I have more companies in me. I'd love my next company to be in Israel." But isn't America the marketplace for big business? "Israel is second only to the Silicon Valley in technology. In chutzpah, vision and opportunities, Israel is number one."


Holograms: Less is More


If photographic images are based on pictures of images as they are, then holograms are a way to produce a picture based on the diffraction, or breaking up of light into the color spectrum. For example, if you were to take a picture of a cat with your camera, the cat obviously would have to be there for its image to appear on film. However, a hologram of the cat is produced by merely recording the patterns of light diffracted from it. A feature of holography is that only a fraction of the diffraction information is required to reconstruct the complete holographic image. If the same concept could be used in computers, that would mean less data for your computer to store. The "lightweight" (meaning less processing and storage space required) images would then be free to race across your screen.
 
Jacob Guedalia and family. Physics and business
English

Family Story

English

Dr. Martin Becker, his wife Rosette and their son Eitan are all alumni of the Weizmann Institute

 

"The immune system fascinated me, even in high school," says Dr. Martin Becker, Feinberg Graduate School Ph.D., '73, now president and CEO of XTL, a company developing therapeutics for viral and autoimmune diseases, and cancer. "The technology that we purchased from Yeda, the Institute's commercial arm, is allowing us to create antibodies which can then be used as drugs." XTL brings its first hepatitis B drug to the clinic in 1998.

Why Weizmann? "I wanted to be in Israel. I am a Zionist. And the Institute is thought of as one of the best immunology study centers in the world." Armed with a Ph.D., then on to Helsinki and San Francisco for post-doctoral research, he returned to Israel in 1976 to run the Clinical Immunology Research Institute, this while teaching at Tel Aviv University's medical school. Then to Syntex (now Roche Bioscience) in Palo Alto; in his last two years he served as VP, Technology, Corporate Business Development.

"We always intended to come back," he says of the family's 1994 return. "We like it here." The "we" is wife Rosette, also a Feinberg graduate and VP of research and development at Orgenics, and their three children. The eldest is Eitan, a recent Feinberg School grad, now working at Compugen, a biotechnology company. Do they talk science over the breakfast table? "Occasionally ­ but not on a regular basis."

For those hoping to pursue a biotech career in Israel, this advice: "Be creative. Let your thoughts run free, even if at first they seem illogical. Mix different scientific areas and activities; this is where you find the interesting things. Don't be afraid to dream."
Dr. Martin Becker, his wife Rosette and their son Eitan are all alumni of the Weizmann Institute
English

A Powerful Idea

English

Alexander Sromin of Samot Engineering

 

A shiny round motor has spun its way around the world, from an impoverished Russian laboratory to an Israeli science park to a Californian manufacturer. Thanks to the determination of a young researcher and a program designed to tap the know-how of immigrant scientists, this invention may power new growth in the production of compact electric motors.

Alexander Sromin's disc-shaped motor, the smallest version of which weighs just 700 grams and is as thin as a slice of bread, is one-third the size of a conventional electric motor. Yet it supplies twice as much power. The lightweight and efficient design makes it ideal for bicycles, wheelchairs and fans, as well as robots and mobile industrial machines.

Sromin created his company, Samot Engineering, through the Kiryat Weizmann Incubator for Technological Entrepreneurship, the first of 26 such incubators established in a
nationwide project in which the Weizmann Institute played a pioneering role. The motor he invented is now being checked against U.S. technical standards by a Californian firm manufacturing battery-run bicycles which plans to order 10,000 motors for sale with its bicycles this year.

Israel's incubator program was launched six years ago to help immigrant scientists with few financial resources get their ideas off the ground. Financed primarily by the Chief Scientist's Office of the Ministry of Trade and Industry, it gives promising entrepreneurs office space, guidance and seed money for two years. Then, they must fend for themselves.

The Kiryat Weizmann Incubator, established and run with the help of the Weizmann Institute and Africa-Israel Investments Ltd., is headed by Dr. Shmuel Yerushalmi, an alumnus of the Institute's Feinberg Graduate School. Seven of its 10 completed projects have proven successful, and 10 more are still in the incubator stage.

Thirty-five-year-old Sromin started working alone out of the incubator office space in the Kiryat Weizmann Industrial Park in 1992, just one year after immigrating from St. Petersburg.

In 1995, he signed a financing deal with German investors who took on a quarter stake in his company for $250,000. Now Sromin has seven employees and high hopes for the future.
 
 
Alexander Sromin
English

A Real Success Out of Virtual Places

English

 

Prof. Ehud Shapiro and America Online CEO Steve Case. real success
 
 

Prof. Ehud Shapiro is riding a wave of success. The 41-year-old Weizmann Institute academic has sailed into the business world, thanks to an innovative interactive computer program that has captured the excitement of the on-line universe.


Israel-born Shapiro, now on leave of absence from the Institute's Applied Mathematics and Computer Science Department, has made a hit with his Virtual Places software, which allows interaction on the World Wide Web part of the Internet. The program enables users to meet at any Web site, explore different sites together and discuss their findings, via computer.

At the Institute, Shapiro's major focus was programming languages and, particularly, logic programming, and he spent a decade participating in Japan's Fifth Generation Project to advance artificial intelligence. Virtual Places arose from that research.

Shapiro was quick to realize the potential of the Internet, the global computer network that has mushroomed exponentially this decade. In late 1993, he took official leave and obtained a license from Yeda Research & Development Co. -- which is responsible for the commercialization of Weizmann Institute research -- to set up a company, Ubique. In March last year, he launched Virtual Places at a computer trade fair. America Online, the giant computer services company, was impressed and offered to buy Ubique. Shapiro sold the company in September 1995, and now serves as Ubique's president, reporting to America Online executives. Ubique's Vice President, Avner Shafrir, and the development staff remain in Rehovot.

In April this year, America Online officially launched Virtual Places for open testing on the Web.
 
Prof. Ehud Shapiro and America Online CEO Steve Case. real success
English

Weizmann Institute Aids Galilee Manufacturer

English
Dr. Vaya (left) finds the odor is just right
 
 

 

Keeping mushroom soup tasting like mushrooms, roses looking rose-colored and ambergris perfume smelling like ambergris are among the tasks performed by the Arogal firm in Kiryat Shmona -- tasks in which it is aided by the Weizmann Institute of Science. Kiryat Shmona is a development town of 18,000 near the troubled Lebanese border, and Arogal is one of over 50 industrial companies established in the Upper Galilee and Golan region in an effort to develop that sparsely settled part of Israel.

Dr. Jacob Vaya, a chemist at Arogal, is spending his sabbatical year at the Weizmann Institute, where he is studying techniques for the synthesis of various natural compounds with unique tastes, colors and odors. Arogal is the only plant in Israel that produces such natural compounds, which are important to both the food and the cosmetics industry.

Working with Prof. Mario David Bachi and his group in the Organic Chemistry Department, Dr. Vaya is developing synthetic methods for converting sclareol -- a natural substance extracted from sage -- into ambrox, a form of ambergris, whose aroma is highly sought after by perfume manufacturers.

Arogal was set up by the Galilee Technological Center (Migal) -- a research institute founded 12 years ago by the kibbutzim in the area -- in partnership with Israel Chemicals Ltd. Besides engaging in research that can lead to the establishment of technologically oriented local industries, Migal provides such industries with ongoing R&D support and quality control for their products.

In his work at Arogal, Dr. Vaya isolates and characterizes the natural essences that give certain plants their commercially desirable properties, and then refines these properties. In a related project, he attempts to regulate the biosynthesis of some secondary metabolites in plants so as to substantially increase the level of such fragrances.

For Dr. Vaya, research in Prof. Bachi's laboratory is nothing new: Prof. Bachi was his mentor during Vaya's doctoral studies at the Weizmann Institute Feinberg Graduate School. After completing his postdoctoral work at Boston College, Dr. Vaya engaged in the development of therapeutic drugs at Teva Pharmaceutical Industries in Jerusalem before joining the ranks of Arogal.

Prof. Bachi is the incumbent of the Charles and Charlotte Krown Chair of Medicinal Chemistry.
 
Dr. Jacob Vaya
English

Pages